Skip to content

COVID-19 is an emerging, rapidly evolving situation.

Get the latest public health information from CDC: https://www.coronavirus.gov
Get the latest research information from NIH: https://www.nih.gov/coronavirus

National Advisory Mental Health Council (NAMHC) Workgroups

Clinical High Risk for Psychosis Workgroup of Council

The Clinical High Risk (CHR) for Psychosis Workgroup brings together key public and private stakeholders in early intervention for schizophrenia, to advise the National Advisory Mental Health Council on initiatives to qualify biomarkers and clinical endpoints that reliably predict psychosis and non-psychosis outcomes. More...

Drug Development Workgroup of Council

The Drug Development Workgroup will advise the National Advisory Mental Health Council on future directions in drug development for the treatment of mental disorders.  More...

Opportunities and Challenges of Developing Information Technologies on Behavioral and Social Science Clinical Research

The National Advisory Mental Health Council Workgroup on Behavioral and Social Science Research will review the opportunities and challenges of using new information technologies to study human behaviors relevant to the NIMH mission. More...

NAMHC FAST Workgroup

This Council workgroup is asked to advise the National Advisory Mental Health Council on the most promising molecular targets and compounds for disorders of the mood and anxiety spectrum, the psychotic spectrum and the autism spectrum. More...

Changes to the RDoC Matrix Council Workgroup

The National Advisory Mental Health Council (NAMHC) Workgroup on Changes to the RDoC Matrix (CMAT) advises the council on revisions and modifications to the RDoC matrix. More...